MARKET

IDXG

IDXG

Interpace Biosciences Inc
OTCQX
1.250
-0.050
-3.85%
Closed 15:18 06/21 EDT
OPEN
1.300
PREV CLOSE
1.300
HIGH
1.300
LOW
1.250
VOLUME
7.82K
TURNOVER
10.07K
52 WEEK HIGH
10.51
52 WEEK LOW
0.510
MARKET CAP
5.24M
P/E (TTM)
6.19
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at IDXG last week (0610-0614)?
Weekly Report · 5d ago
Weekly Report: what happened at IDXG last week (0603-0607)?
Weekly Report · 06/10 09:30
INTERPACE DIAGNOSTICS ANNOUNCES NEW DATA ANALYZING IMBALANCE OF SHORT TANDEM REPEAT ALLELES FOR PANCREATIC CANCER DETECTION PUBLISHED AS AN ASCO 2024 ABSTRACT
Reuters · 06/04 12:00
Weekly Report: what happened at IDXG last week (0527-0531)?
Weekly Report · 06/03 09:31
Weekly Report: what happened at IDXG last week (0520-0524)?
Weekly Report · 05/27 09:32
Weekly Report: what happened at IDXG last week (0513-0517)?
Weekly Report · 05/20 09:31
Weekly Report: what happened at IDXG last week (0506-0510)?
Weekly Report · 05/13 09:32
Financial Report: Asuragen, Comerica Bank, and Term Loan Analysis for 2021-2024
Press release · 05/10 21:32
More
About IDXG
Interpace Biosciences, Inc., formerly Interpace Diagnostics Group, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, it provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.

Webull offers Interpace Biosciences Inc stock information, including OTCQX: IDXG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IDXG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IDXG stock methods without spending real money on the virtual paper trading platform.